Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 07:23:31 UTC |
---|
Update Date | 2021-09-26 23:01:50 UTC |
---|
HMDB ID | HMDB0250388 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Cobimetinib |
---|
Description | Cobimetinib belongs to the class of organic compounds known as anthranilamides. These are aromatic compound containing a benzene carboxamide moiety that carries an amine group at the 2-position of the benzene ring. Based on a literature review a significant number of articles have been published on Cobimetinib. This compound has been identified in human blood as reported by (PMID: 31557052 ). Cobimetinib is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Cobimetinib is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | OC1(CN(C1)C(=O)C1=C(NC2=C(F)C=C(I)C=C2)C(F)=C(F)C=C1)C1CCCCN1 InChI=1S/C21H21F3IN3O2/c22-14-6-5-13(19(18(14)24)27-16-7-4-12(25)9-15(16)23)20(29)28-10-21(30,11-28)17-3-1-2-8-26-17/h4-7,9,17,26-27,30H,1-3,8,10-11H2 |
---|
Synonyms | Not Available |
---|
Chemical Formula | C21H21F3IN3O2 |
---|
Average Molecular Weight | 531.318 |
---|
Monoisotopic Molecular Weight | 531.06306 |
---|
IUPAC Name | 1-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzoyl}-3-(piperidin-2-yl)azetidin-3-ol |
---|
Traditional Name | 1-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzoyl}-3-(piperidin-2-yl)azetidin-3-ol |
---|
CAS Registry Number | Not Available |
---|
SMILES | OC1(CN(C1)C(=O)C1=C(NC2=C(F)C=C(I)C=C2)C(F)=C(F)C=C1)C1CCCCN1 |
---|
InChI Identifier | InChI=1S/C21H21F3IN3O2/c22-14-6-5-13(19(18(14)24)27-16-7-4-12(25)9-15(16)23)20(29)28-10-21(30,11-28)17-3-1-2-8-26-17/h4-7,9,17,26-27,30H,1-3,8,10-11H2 |
---|
InChI Key | BSMCAPRUBJMWDF-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as anthranilamides. These are aromatic compound containing a benzene carboxamide moiety that carries an amine group at the 2-position of the benzene ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Benzoic acids and derivatives |
---|
Direct Parent | Anthranilamides |
---|
Alternative Parents | |
---|
Substituents | - Aminobenzamide
- Anthranilamide
- Aminobenzoic acid or derivatives
- 3-halobenzoic acid or derivatives
- 2-aminobenzamide
- 4-halobenzoic acid or derivatives
- Halobenzoic acid or derivatives
- Benzoyl
- Aniline or substituted anilines
- Iodobenzene
- Halobenzene
- Fluorobenzene
- Aryl fluoride
- Piperidine
- Aryl halide
- Aryl iodide
- Tertiary carboxylic acid amide
- Tertiary alcohol
- Vinylogous amide
- 1,2-aminoalcohol
- Amino acid or derivatives
- Azetidine
- Carboxamide group
- Azacycle
- Secondary amine
- Organoheterocyclic compound
- Secondary aliphatic amine
- Carboxylic acid derivative
- Organonitrogen compound
- Alcohol
- Organooxygen compound
- Amine
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Organohalogen compound
- Organofluoride
- Organoiodide
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Cobimetinib,2TMS,isomer #1 | C[Si](C)(C)OC1(C2CCCCN2[Si](C)(C)C)CN(C(=O)C2=CC=C(F)C(F)=C2NC2=CC=C(I)C=C2F)C1 | 3435.9 | Semi standard non polar | 33892256 | Cobimetinib,2TMS,isomer #1 | C[Si](C)(C)OC1(C2CCCCN2[Si](C)(C)C)CN(C(=O)C2=CC=C(F)C(F)=C2NC2=CC=C(I)C=C2F)C1 | 3271.6 | Standard non polar | 33892256 | Cobimetinib,2TMS,isomer #1 | C[Si](C)(C)OC1(C2CCCCN2[Si](C)(C)C)CN(C(=O)C2=CC=C(F)C(F)=C2NC2=CC=C(I)C=C2F)C1 | 3886.2 | Standard polar | 33892256 | Cobimetinib,2TMS,isomer #2 | C[Si](C)(C)OC1(C2CCCCN2)CN(C(=O)C2=CC=C(F)C(F)=C2N(C2=CC=C(I)C=C2F)[Si](C)(C)C)C1 | 3324.5 | Semi standard non polar | 33892256 | Cobimetinib,2TMS,isomer #2 | C[Si](C)(C)OC1(C2CCCCN2)CN(C(=O)C2=CC=C(F)C(F)=C2N(C2=CC=C(I)C=C2F)[Si](C)(C)C)C1 | 3259.5 | Standard non polar | 33892256 | Cobimetinib,2TMS,isomer #2 | C[Si](C)(C)OC1(C2CCCCN2)CN(C(=O)C2=CC=C(F)C(F)=C2N(C2=CC=C(I)C=C2F)[Si](C)(C)C)C1 | 3659.7 | Standard polar | 33892256 | Cobimetinib,2TMS,isomer #3 | C[Si](C)(C)N(C1=CC=C(I)C=C1F)C1=C(F)C(F)=CC=C1C(=O)N1CC(O)(C2CCCCN2[Si](C)(C)C)C1 | 3337.1 | Semi standard non polar | 33892256 | Cobimetinib,2TMS,isomer #3 | C[Si](C)(C)N(C1=CC=C(I)C=C1F)C1=C(F)C(F)=CC=C1C(=O)N1CC(O)(C2CCCCN2[Si](C)(C)C)C1 | 3283.9 | Standard non polar | 33892256 | Cobimetinib,2TMS,isomer #3 | C[Si](C)(C)N(C1=CC=C(I)C=C1F)C1=C(F)C(F)=CC=C1C(=O)N1CC(O)(C2CCCCN2[Si](C)(C)C)C1 | 3805.8 | Standard polar | 33892256 | Cobimetinib,3TMS,isomer #1 | C[Si](C)(C)OC1(C2CCCCN2[Si](C)(C)C)CN(C(=O)C2=CC=C(F)C(F)=C2N(C2=CC=C(I)C=C2F)[Si](C)(C)C)C1 | 3351.9 | Semi standard non polar | 33892256 | Cobimetinib,3TMS,isomer #1 | C[Si](C)(C)OC1(C2CCCCN2[Si](C)(C)C)CN(C(=O)C2=CC=C(F)C(F)=C2N(C2=CC=C(I)C=C2F)[Si](C)(C)C)C1 | 3325.6 | Standard non polar | 33892256 | Cobimetinib,3TMS,isomer #1 | C[Si](C)(C)OC1(C2CCCCN2[Si](C)(C)C)CN(C(=O)C2=CC=C(F)C(F)=C2N(C2=CC=C(I)C=C2F)[Si](C)(C)C)C1 | 3576.2 | Standard polar | 33892256 | Cobimetinib,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1(C2CCCCN2[Si](C)(C)C(C)(C)C)CN(C(=O)C2=CC=C(F)C(F)=C2NC2=CC=C(I)C=C2F)C1 | 3876.3 | Semi standard non polar | 33892256 | Cobimetinib,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1(C2CCCCN2[Si](C)(C)C(C)(C)C)CN(C(=O)C2=CC=C(F)C(F)=C2NC2=CC=C(I)C=C2F)C1 | 3643.8 | Standard non polar | 33892256 | Cobimetinib,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1(C2CCCCN2[Si](C)(C)C(C)(C)C)CN(C(=O)C2=CC=C(F)C(F)=C2NC2=CC=C(I)C=C2F)C1 | 3971.9 | Standard polar | 33892256 | Cobimetinib,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1(C2CCCCN2)CN(C(=O)C2=CC=C(F)C(F)=C2N(C2=CC=C(I)C=C2F)[Si](C)(C)C(C)(C)C)C1 | 3727.4 | Semi standard non polar | 33892256 | Cobimetinib,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1(C2CCCCN2)CN(C(=O)C2=CC=C(F)C(F)=C2N(C2=CC=C(I)C=C2F)[Si](C)(C)C(C)(C)C)C1 | 3663.3 | Standard non polar | 33892256 | Cobimetinib,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1(C2CCCCN2)CN(C(=O)C2=CC=C(F)C(F)=C2N(C2=CC=C(I)C=C2F)[Si](C)(C)C(C)(C)C)C1 | 3734.9 | Standard polar | 33892256 | Cobimetinib,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N(C1=CC=C(I)C=C1F)C1=C(F)C(F)=CC=C1C(=O)N1CC(O)(C2CCCCN2[Si](C)(C)C(C)(C)C)C1 | 3791.4 | Semi standard non polar | 33892256 | Cobimetinib,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N(C1=CC=C(I)C=C1F)C1=C(F)C(F)=CC=C1C(=O)N1CC(O)(C2CCCCN2[Si](C)(C)C(C)(C)C)C1 | 3657.6 | Standard non polar | 33892256 | Cobimetinib,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N(C1=CC=C(I)C=C1F)C1=C(F)C(F)=CC=C1C(=O)N1CC(O)(C2CCCCN2[Si](C)(C)C(C)(C)C)C1 | 3920.0 | Standard polar | 33892256 | Cobimetinib,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1(C2CCCCN2[Si](C)(C)C(C)(C)C)CN(C(=O)C2=CC=C(F)C(F)=C2N(C2=CC=C(I)C=C2F)[Si](C)(C)C(C)(C)C)C1 | 3983.2 | Semi standard non polar | 33892256 | Cobimetinib,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1(C2CCCCN2[Si](C)(C)C(C)(C)C)CN(C(=O)C2=CC=C(F)C(F)=C2N(C2=CC=C(I)C=C2F)[Si](C)(C)C(C)(C)C)C1 | 3865.6 | Standard non polar | 33892256 | Cobimetinib,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1(C2CCCCN2[Si](C)(C)C(C)(C)C)CN(C(=O)C2=CC=C(F)C(F)=C2N(C2=CC=C(I)C=C2F)[Si](C)(C)C(C)(C)C)C1 | 3726.6 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Cobimetinib GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Cobimetinib GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Cobimetinib GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Cobimetinib GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Cobimetinib GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Cobimetinib GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cobimetinib 10V, Positive-QTOF | splash10-001i-0000090000-cddc2d7ac7cf2a9c9061 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cobimetinib 20V, Positive-QTOF | splash10-001i-0202290000-ade917d8f2b35c13de7c | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cobimetinib 40V, Positive-QTOF | splash10-0gz0-1914340000-3617b697d1699aba230a | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cobimetinib 10V, Negative-QTOF | splash10-001i-0000090000-0b4d5628fc60eca54897 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cobimetinib 20V, Negative-QTOF | splash10-01q9-0200190000-777a59e2fcf5ee787e17 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cobimetinib 40V, Negative-QTOF | splash10-004i-3903440000-78e54c122000cf9613ed | 2021-10-12 | Wishart Lab | View Spectrum |
|
---|